Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 131 results
Author Title [ Year(Desc)]
Filters: Author is Fisher, Brian T  [Clear All Filters]
2015
Chellapandian DB, Lehrnbecher T, Phillips B, et al. "Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis." J. Clin. Oncol.. 2015;33(5):501-9.
Lee GE, Fisher BT, Xiao R, et al. "Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic Leukemia." J Pediatric Infect Dis Soc. 2015;4(4):290-6.
Patel RR, Hodinka RL, Kajon AE, et al. "A Case of Adenovirus Viremia in a Pediatric Liver Transplant Recipient With Neutropenia and Lymphopenia: Who and When Should We Treat?" J Pediatric Infect Dis Soc. 2015;4(1):e1-5.
Fisher BT, Vendetti N, Bryan M, et al. "Central Venous Catheter Retention and Mortality in Children With Candidemia: A Retrospective Cohort Analysis." J Pediatric Infect Dis Soc. 2015.
Miller TP, Troxel AB, Li Y, et al. "Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(7):1184-9.
Getz KD, Li Y, Alonzo TA, et al. "Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(10):1775-81.
Getz KD, Miller TP, Seif AE, et al. "A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia." Cancer Med. 2015;4(9):1356-64.
Seif AE, Walker DM, Li Y, et al. "Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients." Pediatr Blood Cancer. 2015;62(4):704-9.
Fisher BT, Ross RK, Roilides E, et al. "Failure to Validate a Multivariable Clinical Prediction Model to Identify Pediatric Intensive Care Unit Patients at High Risk for Candidemia." J Pediatric Infect Dis Soc. 2015.
Li Y, Hall M, Fisher BT, et al. "Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group." PLoS ONE. 2015;10(11):e0143480.
Wattier RL, Dvorak CC, Hoffman JA, et al. "A Prospective, International Cohort Study of Invasive Mold Infections in Children." J Pediatric Infect Dis Soc. 2015;4(4):313-22.
Klieger SB, Vendetti N, Fisher BT, Gerber JS. "Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes." Infect Control Hosp Epidemiol. 2015;36(5):603-5.
Martino J, Fisher BT, Bosse KR, Bagatell R. "Suspected posaconazole toxicity in a pediatric oncology patient." Pediatr Blood Cancer. 2015;62(9):1682.
2016
Miller TP, Li Y, Kavcic M, et al. "Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia." J. Clin. Oncol.. 2016.
Vendetti N, Gerber JS, Sammons JS, Fisher BT, Zaoutis TE, Coffin SE. "Administration of Palivizumab in the NICU." Hosp Pediatr. 2016.
DiNofia AM, Salazar EG, Seif AE, et al. "Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States." PLoS ONE. 2016;11(3):e0151362.
Chiotos K, Vendetti N, Zaoutis TE, et al. "Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12)." J. Antimicrob. Chemother.. 2016;71(12):3536-3539.
Vendetti N, Bryan M, Zaoutis TE, Damianos A, Fisher BT. "Comparative effectiveness of fungicidal vs. fungistatic therapies for the treatment of paediatric candidaemia." Mycoses. 2016;59(3):173-8.
Miller TP, Getz KD, Kavcic M, et al. "A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group." Leuk. Lymphoma. 2016:1-8.
Getz KD, Miller TP, Seif AE, et al. "Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report." Cancer Med. 2016.
Lehrnbecher T, Robinson PD, Fisher BT, et al. "Galactomannan, Beta-D-Glucan and PCR-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis." Clin. Infect. Dis.. 2016;63(10).

Pages